Search Tag: Tomosynthesis

IMAGING Management

In Breast Cancer Detection, the Evidence Points to Tomosynthesis

2013 17 Sep

Growing number of peer-reviewed clinical publications document significant advantages of  H ologic® tomosynthesis; Now, Hologic has further advanced tomosynthesis with faster and  lower-dose options including the C-View™ software option for 2D imaging and the Affirm™  tomosynthesis biopsy procedure. Tomosynthesis is going from strength... Read more

IMAGING Management

GE Healthcare Breast Tomosynthesis Solution Gains CE Marking

2013 02 Aug

GE Healthcare has announced CE marking for SenoClaire, GE’s new generation of breast tomosynthesis solution designed with a three-dimensional imaging technology. SenoClaire technology uses a low-dose short X-ray sweep around the positioned breast with nine exposures acquired with a “step-and-shoot” method, removing the potential motion from images.... Read more

IMAGING Management

30 Percent Reduction in Breast Cancer Screening Recall Rate with Tomosynthesis: New Study

2013 30 Jul

Digital tomosynthesis is effective in reducing the recall rate in breast cancer screening, according to a new study published online in the journal Radiology.  Tomosynthesis is similar to mammography in that it relies on ionising radiation to generate images of the breast. However, unlike conventional mammography, tomosynthesis allows for three-dimensional... Read more

IMAGING Management

Hologic's Breast Tomosynthesis Reduces Recall Rates and Improves Cancer Detection - U.S. Study

2013 24 May

Hologic has announced that the first large-scale observational study in a U.S. clinical practice comparing breast cancer screening with Hologic's 3D mammography technology (breast tomosynthesis) with conventional 2D mammography alone showed a significant reduction in recall rates and a sizeable increase in cancer detection, particularly invasive cancer,... Read more

IMAGING Management

Hologic Gets FDA Approval for New Low-Dose Breast Tomosynthesis Solution

2013 24 May

Hologic has announced US Food and Drug Administration approval of its new C-View 2D imaging software. C-View 2D images may now be used in place of the conventional 2D exposure previously required as part of a Hologic 3D mammography (breast tomosynthesis) screening exam. C-View images are generated from the 3D tomosynthesis data acquired during... Read more

IMAGING Management

Benefits of Hologic's Breast Tomosynthesis Supported in Published Italian Study

2013 09 May

Hologic has announced the publication of the final results of a large-scale prospective study comparing breast cancer screening using Hologic's 2D mammography plus tomosynthesis (Breast Tomosynthesis) with conventional 2D mammography published online in advance of print by The Lancet Oncology. The study, "Integration of 3D digital mammography with... Read more

IMAGING Management

New Study Further Supports Hologic's Breast Tomosynthesis in Cancer Screening

2013 22 Apr

Hologic has announced that a new study published online by European Radiology supports the use of breast tomosynthesis in combination with 2-dimensional (2D) imaging in breast cancer screening programmes using independent double reading with arbitration. The study, " Prospective Trial Comparing Full-field Digital Mammography (FFDM) versus Combined... Read more

IMAGING Management

Breast Tomosynthesis a Positive Investment

2013 21 Mar

Breast tomosynthesis has created a lot of interest within the women’s imaging community. While the clinical benefits are becoming more apparent, the reimbursements in the U.S. are inconsistent, and it is expensive to adopt this technology. Providers want to know: Is it worth the investment? Is a positive return on investment (ROI) possible? Hologic... Read more

IMAGING Management

Hologic at ECR

2013 06 Mar

Hologic will display an extensive suite of healthcare solutions for breast cancer screening and diagnosis, breast biopsy, osteoporosis risk assessment, medical MRI coils, and extremity imaging at ECR.   David Harding, Hologic's Senior Vice President and General Manager, International says, "Of particular interest this year are advances in our breast... Read more